IJMS | Free Full-Text | Mutational Landscape and Environmental Effects in Bladder Cancer | HTML
Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics: Molecular Therapy - Nucleic Acids
Cancers | Free Full-Text | Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment | HTML
Frontiers | Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy | Immunology
Non-small-cell lung cancer | Nature Reviews Disease Primers
The lung microenvironment: an important regulator of tumour growth and metastasis | Nature Reviews Cancer
Non-small-cell lung cancer | Nature Reviews Disease Primers
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy - eBioMedicine
Cancers | Free Full-Text | Current Perspectives in Cancer Immunotherapy | HTML
Precision oncology in metastatic colorectal cancer — from biology to medicine | Nature Reviews Clinical Oncology
Cytokines in cancer pathogenesis and cancer therapy | Nature Reviews Cancer
Future directions in cancer prevention | Nature Reviews Cancer
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy | Nature Reviews Cancer
Cancers | Free Full-Text | Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer | HTML
Frontiers | Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis | Oncology
Cancer-associated fibroblasts—heroes or villains? | British Journal of Cancer
Lung cancer - The Lancet
Cancers | Free Full-Text | CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy | HTML
The role of vitamin D in reducing cancer risk and progression | Nature Reviews Cancer
Cytokines in cancer pathogenesis and cancer therapy | Nature Reviews Cancer
Diversity and Biology of Cancer-Associated Fibroblasts | Physiological Reviews
Frontiers | Chronic Stress Promotes Cancer Development | Oncology
IJMS | Free Full-Text | Inflammation-Induced Tumorigenesis and Metastasis | HTML
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
Frontiers | Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer | Oncology
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy | Nature Reviews Cancer
